Rapidemic
About:
Rapidemic is a developer of diagnostic kits for infectious diseases.
Website: https://rapidemic.com
Top Investors: Graduate Entrepreneur Fund, BioInnovation Institute
Description:
Rapidemic develops a molecular point-of-care test for the diagnosis of sexually transmitted infections. Their proprietary technology increases the sensitivity and specificity of the reaction while keeping manipulations to a minimum. Its technology enables low-temperature diagnostics while safeguarding accuracy and reducing false positives.
Total Funding Amount:
650000 EUR
Headquarters Location:
Leiden, Zuid-Holland, The Netherlands
Founded Date:
2020-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-08-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai